The proposed company plans to:
a) Reinvent and integrate open-source software and programs developed in-house with a more user-friendly interface at an affordable price.
b) Introduce Machine Learning and Generative AI-based software into biological prediction-based analysis.
c) Generate new standardized pipelines for genome-based and proteome-based analysis.
d) Introduce scripts and programs to fill gaps in biological pipelines for public access and in-house usage.
e) To create an in-house database for: Phytochemicals and drug-like molecules for Computer-aided Drug Design & Genome Variations and Mutations for Genetics and Precision Medicine based in-silico Studies
f) Acquire, Lease, or Purchase Intellectual Property, Patents, and Licenses for technology through collaborations.
g) Secure funding and investments from research projects to expand the company.
h) Provide consultation services to UG, PG, and PhD level users at affordable price
i) To conduct Outreach, Seminars, and Workshops to promote the company and its products.